Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
A Novel Therapeutic Approach: Gamma Secretase Inhibitor Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer.
Journal: Future oncology (London, England)
Published: June 27, 2025
Tissue expander breast reconstruction outcomes following postmastectomy radiation therapy in the era of neoadjuvant chemotherapy.
Journal: Frontiers in oncology
Published: May 27, 2025
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
Journal: Annals of surgical oncology
Published: May 06, 2025
CLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High Risk.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial.
Journal: NPJ breast cancer
Published: February 26, 2025
Keeping the network alive: The importance of professional social networks for long-term research career development.
Journal: Journal of clinical and translational science
Published: November 18, 2024
Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance.
Journal: Cancer research communications
Published: August 09, 2023
Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial.
Journal: JAMA oncology
Published: July 06, 2023
Combining immunotherapy with high-dose radiation therapy (HDRT) significantly inhibits tumor growth in a syngeneic mouse model of high-risk neuroblastoma.
Journal: Heliyon
Published: June 28, 2022
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
Journal: Clinical breast cancer
Published: December 13, 2021
Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience.
Journal: Frontiers in oncology
Published: October 01, 2021
Last Updated: 09/26/2026